Type2diabetes
100
29
37
42
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 100 trials
100.0%
+13.4% vs benchmark
11%
11 trials in Phase 3/4
12%
5 of 42 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 42 completed trials
Clinical Trials (100)
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study
Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
Susceptibility to Infectious Diseases in Obesity
Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes
The PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older
Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity
Integration of a Trained Language Model to Improve Glycemic Control With the My Heart Counts Smartphone App
QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes
Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy
Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
Use of taVNS for Painful Diabetic Neuropathy: 12-Week Randomized, Sham-Controlled Trial
The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
CGM Experience, Preferences & Blood Glucose Parameters